DOCIVYX vs TAXOTERE

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 19, 2026·How we rate

Attribute	DOCIVYX	TAXOTERE
Rating	New	70/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	DOCETAXEL	DOCETAXEL
Manufacturer	Avyxa Holdings	Sanofi Aventis US
Dosage forms	Injectable	Injectable
Drug class	Microtubule Inhibitor	Microtubule Inhibitor
Boxed warning	Boxed warning	Boxed warning
Treats	Breast Neoplasms, Non-Small-Cell Lung Carcinoma, Head and Neck Neoplasms	Breast Neoplasms, Non-Small-Cell Lung Carcinoma, Head and Neck Neoplasms

docivyx taxotere

Rating

New

70/100

Pharmacy pays

—

Type

Active ingredient

DOCETAXEL

Manufacturer

Avyxa Holdings

Sanofi Aventis US

Dosage forms

Injectable

Drug class

Microtubule Inhibitor

Boxed warning

Treats

Breast Neoplasms, Non-Small-Cell Lung Carcinoma, Head and Neck Neoplasms

Frequently asked questions

What is the difference between Docivyx and Taxotere?

Both Docivyx and Taxotere share the active ingredient Docetaxel.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.